KCT0008248尚未招募未知
Effect of Intravenous Maxigesic on postoperative pain after ambulatory hysteroscopy surgery
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 18(Year) 至 65(Year)（—）
- 性别
- Female
入选标准
- •Outpatients undergoing hysteroscopy under general anesthesia at our hospital
- •-Adult female patients between the ages of 18 and 65 who agreed to participate in the study
- •-BMI < 30 kg/m2
- •-ASA Physical Status Classification 1 or 2
排除标准
- •? A history of allergic reaction or clinically significant hypersensitivity to acetaminophen, aspirin, opioids, or any non-steroidal anti-inflammatory drug (NSAID, including ibuprofen). history of NSAID-induced bronchospasm (subjects with triad of asthma, nasal polyps, and chronic rhinitis are at greater risk of bronchospasm and should be carefully considered); or hypersensitivity, allergy, or serious reaction to any other drug used in the study, including sulfa (including sulfonamides) medicines, ingredients of the study drug, or anesthetics and antibiotics that may be needed on the day of surgery
- •? Patients who have taken the following drugs: barbiturates, tricyclic antidepressants
- •? When participating in the study, experiencing any surgical complications or other problems that may compromise the safety of the subjects or confuse the results of the study
- •? Known or suspected history of alcoholism or substance abuse or misuse within the last 2 years, or evidence of tolerance or physical dependence prior to administration of study drug
- •? Have a clinically significant unstable cardiac, respiratory, neurological, immune, blood, or kidney disease or other condition that, in the judgment of the researcher, could impair the subject's well-being, ability to communicate with research staff, or otherwise preclude participation in the study Occation
- •? History of or current diagnosis of a serious mental disorder that would affect the subject's ability to comply with the study requirements.
- •? In case of positive reaction in urine drug test or alcohol breathalyzer test
- •? If there is a history of clinically significant gastrointestinal event within 6 months prior to screening, or a history of peptic or gastric ulcer or intestinal bleeding
- •? Surgical or medical conditions of the gastrointestinal tract or renal system that can significantly alter the absorption, distribution or excretion of a drug component.
- •? If the researcher judges that the researcher is not suitable for receiving the study drug for any reason
- •? Receiving systemic chemotherapy, having active malignancy of any type, or having been diagnosed with cancer within 5 years prior to screening (except for treated squamous or basal cell carcinoma of the skin)
- •? If you are currently receiving anticoagulants (e.g. heparin or warfarin)
- •? Those who have received a course of systemic corticosteroids (oral or parenteral) within 3 months prior to screening (topical/limited application of inhaled nasal steroids and topical corticosteroids (at the investigator's discretion) is permitted)
- •? History of chronic use (defined as daily use for >2 weeks) of NSAIDs, opioids, or glucocorticoids (excluding inhaled nasal steroids and topical/restricted topical corticosteroids) for any condition within 6 months prior to study drug administration Inclusion, if any, is determined by the researcher.
- •? Significant renal or liver disease in clinical laboratory evaluation (for all liver function tests including AST, ALT, the result is 3 times the upper limit of normal [ULN] or more, or Cr is 1.5 times the upper limit of normal or more.
- •16 If you have previously participated in another clinical study of Maxigesic® IV or received an investigational drug or device or investigational therapy within 30 days before screening, if there are significant results of other screening tests, the investigator decides whether to participate or not.
研究者
相似试验
尚未招募
4 期
A clinical study to investigate the efficacy of infusion of dextrose containing fluid in decreasing nausea and vomiting in patients undergoing key hole gall bladder surgery.CTRI/2018/10/016224Gauhati Medical College and Hospital
尚未招募
Unknown
The effect seen after giving intraoperative intravenous magnesium sulphate on post operative pain and analgesic consumption after major spine surgeriesCTRI/2023/05/052482Mahatma Gandhi medical College and hospital
招募中
不适用
Magnesium in open shoulder surgeryPost-operative PainOpen Shoulder SurgeryACTRN12617001320347Melbourne Orthopaedic Group50
已完成
不适用
The effect of perioperative intravenous volume and intestinal edema by preoerative OS-1 administration in laparoscopic distal gastrectomy.gastric cncerJPRN-UMIN000019813Saga University Hospital24
进行中（未招募）
不适用
Evaluation of the effect of in-vein Lidocaine done on the surgery time on pain intensity and inflammatory substance concentration (IL-6) in patients submitted to Stomach Reduction Surgery by VideoObesidade não especificadaE66.9RBR-8dghscniversidade Federal do Maranhão